Secretin and cholecystokin-pancreozymin in combination in the inhibition of gastric acid secretion

dc.contributor.author	Bedi, BS
dc.contributor.author	Debas, HT
dc.contributor.author	Wasunna, AE
dc.contributor.author	Buxton, BF
dc.contributor.author	Gillespie, IE
dc.date.accessioned	2013-05-30T07:57:51Z
dc.date.available	2013-05-30T07:57:51Z
dc.date.issued	1971-12
dc.identifier.citation	Gut. 1971 Dec;12(12):968-72	en
dc.identifier.uri	http://www.ncbi.nlm.nih.gov/pubmed/5157135
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/27412
dc.identifier.uri	http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1411986/
dc.description.abstract	Both secretin, and the single substance which possesses both cholecystokinin and pancreozymin activity, have been shown to inhibit gastric acid secretory responses. Since potentiation may occur between pairs of stimulants of gastric secretion, the effects of combining secretin and cholecystokinin/pancreozymin have been studied in Heidenhain pouches stimulated by continuous intravenous pentagastrin. Evidence suggesting potentiation between these two inhibitor agents is presented	en
dc.language.iso	en	en
dc.publisher	University of Nairobi	en
dc.title	Secretin and cholecystokin-pancreozymin in combination in the inhibition of gastric acid secretion	en
dc.type	Article	en
local.publisher	School of medicine	en